$PCOR
PROCORE TECHNOLOGIES, INC. Stock $pcor

$pcor Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023016126 Filed on May 05, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$228.5M	$213.5M	$159.5M
YoY Change	32.71%	33.86%	40.0%
Cost Of Revenue	$42.30M	$40.20M	$33.33M
YoY Change	15.16%	20.61%	63.72%
Gross Profit	$186.2M	$173.3M	$126.2M
YoY Change	37.47%	37.36%	34.84%
Gross Profit Margin	81.49%	81.17%	79.1%
Selling, General & Admin	$168.1M	$162.6M	$137.1M
YoY Change	16.77%	18.59%	90.66%
% of Gross Profit	90.26%	93.78%	108.62%
Research & Development	$72.34M	$80.04M	$60.25M
YoY Change	13.34%	32.83%	74.42%
% of Gross Profit	38.84%	46.18%	47.75%
Depreciation & Amortization	$17.34M	$16.87M	$15.15M
YoY Change	12.55%	11.4%	107.46%
% of Gross Profit	9.31%	9.74%	12.0%
Operating Expenses	$244.2M	$242.6M	$197.3M
YoY Change	17.54%	22.94%	85.39%
Operating Profit	-$57.98M	-$69.26M	-$71.14M
YoY Change	-19.81%	-2.63%	453.25%
Interest Expense	$4.452M	$496.0K	$491.0K
YoY Change	3910.81%	1.02%	-12.63%
% of Operating Profit
Other Income/Expense, Net	$1.718M	-$210.0K	$543.0K
YoY Change	-293.03%	-138.67%	-396.72%
Pretax Income	-$52.56M	-$63.39M	-$71.09M
YoY Change	-28.08%	-10.83%	422.57%
Income Tax	$322.0K	$100.0K	$300.0K
% Of Pretax Income
Net Earnings	-$52.88M	-$63.45M	-$71.42M
YoY Change	-27.68%	-11.16%	420.09%
Net Earnings / Revenue	-23.14%	-29.71%	-44.77%
Basic Earnings Per Share	-$0.37	-$0.45	-$0.53
Diluted Earnings Per Share	-$0.37	-$0.45	-$530.9K
COMMON SHARES
Basic Shares Outstanding	140.5M shares	140.3M	134.5M shares
Diluted Shares Outstanding	141.2M shares	139.6M shares	134.5M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$603.0M	$602.8M	$586.9M
YoY Change	7.06%	2.71%	41.84%
Cash & Equivalents	$312.5M	$329.0M	$586.9M
Short-Term Investments	$290.4M	$273.8M
Other Short-Term Assets	$43.71M	$41.78M	$40.73M
YoY Change	-0.84%	2.57%	89.44%
Inventory
Prepaid Expenses
Receivables	$151.2M	$106.2M	$98.14M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$797.9M	$775.0M	$725.8M
YoY Change	11.47%	6.78%	43.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$113.0M	$38.28M	$126.2M
YoY Change	175.44%	-69.68%	5.64%
Goodwill	$539.4M	$539.1M	$540.0M
YoY Change	-0.04%	-0.17%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$18.64M	$21.86M	$24.09M
YoY Change	-20.91%	-9.26%	74.54%
Total Long-Term Assets	$928.0M	$936.2M	$946.5M
YoY Change	-1.91%	-1.09%	187.86%
TOTAL ASSETS
Total Short-Term Assets	$797.9M	$775.0M	$725.8M
Total Long-Term Assets	$928.0M	$936.2M	$946.5M
Total Assets	$1.726B	$1.711B	$1.672B
YoY Change	3.85%	2.33%	100.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.54M	$19.45M	$14.41M
YoY Change	-26.88%	35.0%	161.96%
Accrued Expenses	$60.09M	$69.63M	$58.89M
YoY Change	15.36%	18.22%	80.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$519.9M	$514.7M	$408.6M
YoY Change	23.97%	25.96%	50.39%
LONG-TERM LIABILITIES
Long-Term Debt	$44.57M	$45.13M	$46.95M
YoY Change	-4.04%	-3.88%	-3.19%
Other Long-Term Liabilities	$45.06M	$4.245M	$52.31M
YoY Change	1207.92%	-91.89%	0.4%
Total Long-Term Liabilities	$89.63M	$4.245M	$99.26M
YoY Change	2501.8%	-95.72%	-1.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$519.9M	$514.7M	$408.6M
Total Long-Term Liabilities	$89.63M	$4.245M	$99.26M
Total Liabilities	$609.5M	$606.8M	$507.9M
YoY Change	18.13%	19.48%	36.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.065B	-$1.013B
YoY Change	32.07%
Common Stock	$14.00K	$14.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.116B	$1.104B	$1.164B
YoY Change
Total Liabilities & Shareholders Equity	$1.726B	$1.711B	$1.672B
YoY Change	3.85%	2.33%	100.2%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$52.88M	-$63.45M	-$71.42M
YoY Change	-27.68%	-11.16%	420.09%
Depreciation, Depletion And Amortization	$17.34M	$16.87M	$15.15M
YoY Change	12.55%	11.4%	107.46%
Cash From Operating Activities	-$11.68M	$29.28M	$10.28M
YoY Change	-56.68%	184.67%	-63.66%
INVESTING ACTIVITIES
Capital Expenditures	$11.92M	$2.173M	$7.525M
YoY Change	-213.23%	-71.12%	214.46%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$15.60M	$10.05M	-$1.038M
YoY Change	323.16%	-1067.73%
Cash From Investing Activities	-$27.52M	-$79.00K	-$16.20M
YoY Change	93.62%	-99.51%	253.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	19.70M	$3.312M	6.542M
YoY Change	6.73%	-49.37%	-39.27%
NET CHANGE
Cash From Operating Activities	-11.68M	$29.28M	10.28M
Cash From Investing Activities	-27.52M	-$79.00K	-16.20M
Cash From Financing Activities	19.70M	$3.312M	6.542M
Net Change In Cash	-19.50M	$32.51M	631.0K
YoY Change	-14.14%	5051.82%	-98.17%
FREE CASH FLOW
Cash From Operating Activities	-$11.68M	$29.28M	$10.28M
Capital Expenditures	$11.92M	$2.173M	$7.525M
Free Cash Flow	-$23.60M	$27.10M	$2.759M
YoY Change	43.65%	882.31%	-89.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001611052
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40396
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Procore Technologies, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	73-1636261
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6309 Carpinteria Avenue
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Carpinteria
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93013
CY2023Q1	dei	City Area Code CityAreaCode	866
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	477-6267
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	PCOR
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	140497548	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	328964000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	296712000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	274029000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	286001000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	273845000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	285493000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3232000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4113000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	106188000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	148683000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	24220000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	23600000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41777000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	44731000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	774994000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	799219000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	64734000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	58577000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38282000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39193000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	36353000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	37026000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41910000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41934000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	40299000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	40477000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	153622000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	162953000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	539129000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	539128000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21856000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21903000	usd
CY2023Q1	us-gaap	Assets Assets	1711179000	usd
CY2022Q4	us-gaap	Assets Assets	1740410000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	19451000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14282000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	69625000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	99182000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	403012000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	396535000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22598000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	21639000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	514686000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	531638000	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5536000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5278000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	45130000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	45578000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37230000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38087000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4245000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3049000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	606827000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	623630000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	140371688	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	140371688	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139159534	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139159534	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2118936000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2068225000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2008000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2316000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1012590000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-949143000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1104352000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1116780000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1711179000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1740410000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	213526000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	159516000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	40202000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	33332000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	173324000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	126184000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	117363000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	93915000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	80036000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	60254000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	45188000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	43152000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	242587000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	197321000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-69263000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-71137000	usd
CY2023Q1	pcor	Interest Income InterestIncome	4948000	usd
CY2022Q1	pcor	Interest Income InterestIncome	74000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	496000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	565000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1632000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-210000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	543000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63389000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71085000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	308000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	334000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-63447000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-71419000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139646465	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139646465	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	134530010	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	134530010	shares
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-16000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	345000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	324000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-71419000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	345000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-63139000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-71074000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1189289000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6795000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39375000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	345000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-71419000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1164385000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1116780000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3651000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	47060000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	308000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-63447000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1104352000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-63447000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	44938000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	37209000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16874000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15147000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1632000	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-441000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q1	pcor	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	2628000	usd
CY2022Q1	pcor	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	2156000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-408000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	477000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-352000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1726000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-98000	usd
CY2023Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	36000	usd
CY2022Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-42948000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-34473000	usd
CY2023Q1	pcor	Increase Decrease In Deferred Contract Cost Assets IncreaseDecreaseInDeferredContractCostAssets	460000	usd
CY2022Q1	pcor	Increase Decrease In Deferred Contract Cost Assets IncreaseDecreaseInDeferredContractCostAssets	4066000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4549000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5175000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4648000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	339000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-28181000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-4357000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6489000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	8774000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2620000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1870000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	29275000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10284000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2173000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7525000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	7951000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	7632000	usd
CY2023Q1	pcor	Payments To Acquire Strategic Investments PaymentsToAcquireStrategicInvestments	149000	usd
CY2022Q1	pcor	Payments To Acquire Strategic Investments PaymentsToAcquireStrategicInvestments	2329000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	89996000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	103909000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
CY2023Q1	pcor	Proceeds To Acquire Originations Of Materials Financing ProceedsToAcquireOriginationsOfMaterialsFinancing	9077000	usd
CY2022Q1	pcor	Proceeds To Acquire Originations Of Materials Financing ProceedsToAcquireOriginationsOfMaterialsFinancing	0	usd
CY2023Q1	pcor	Proceeds To Acquire Customer Repayments Of Materials Financing ProceedsToAcquireCustomerRepaymentsOfMaterialsFinancing	5358000	usd
CY2022Q1	pcor	Proceeds To Acquire Customer Repayments Of Materials Financing ProceedsToAcquireCustomerRepaymentsOfMaterialsFinancing	0	usd
CY2023Q1	pcor	Settlement Of Post Close Working Capital Adjustments From Business Combinations SettlementOfPostCloseWorkingCapitalAdjustmentsFromBusinessCombinations	0	usd
CY2022Q1	pcor	Settlement Of Post Close Working Capital Adjustments From Business Combinations SettlementOfPostCloseWorkingCapitalAdjustmentsFromBusinessCombinations	1291000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16195000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3722000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6907000	usd
CY2023Q1	pcor	Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives	410000	usd
CY2022Q1	pcor	Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives	365000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3312000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6542000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	32508000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	631000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-256000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	299816000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	589212000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	332068000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	590018000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	328964000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	586914000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3104000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3104000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	332068000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	590018000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	38000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	79000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	98000	usd
CY2023Q1	pcor	Stock Based Compensation Capitalized For Cloud Computing Arrangement Costs StockBasedCompensationCapitalizedForCloudComputingArrangementCosts	69000	usd
CY2022Q1	pcor	Stock Based Compensation Capitalized For Cloud Computing Arrangement Costs StockBasedCompensationCapitalizedForCloudComputingArrangementCosts	44000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	239000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	405000	usd
CY2023Q1	pcor	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	496000	usd
CY2022Q1	pcor	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	511000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3119000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2518000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	496000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	454000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1306000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1521000	usd
CY2023Q1	pcor	Increase Decrease In Accruals For Capitalized Software Development Costs IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts	2088000	usd
CY2022Q1	pcor	Increase Decrease In Accruals For Capitalized Software Development Costs IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts	1829000	usd
CY2023Q1	pcor	Net Change In Deferred Offering Costs Accrued But Not Paid NetChangeInDeferredOfferingCostsAccruedButNotPaid	0	usd
CY2022Q1	pcor	Net Change In Deferred Offering Costs Accrued But Not Paid NetChangeInDeferredOfferingCostsAccruedButNotPaid	270000	usd
CY2023Q1	pcor	Stock Based Compensation Capitalized For Software Development StockBasedCompensationCapitalizedForSoftwareDevelopment	2053000	usd
CY2022Q1	pcor	Stock Based Compensation Capitalized For Software Development StockBasedCompensationCapitalizedForSoftwareDevelopment	2122000	usd
CY2023Q1	pcor	Conversion Of Available For Sale Debt Securities Into Equity Securities ConversionOfAvailableForSaleDebtSecuritiesIntoEquitySecurities	0	usd
CY2022Q1	pcor	Conversion Of Available For Sale Debt Securities Into Equity Securities ConversionOfAvailableForSaleDebtSecuritiesIntoEquitySecurities	3292000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2615000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6993000	usd
CY2023Q1	pcor	Noncash Net Change Due To Operating Lease Remeasurements NoncashNetChangeDueToOperatingLeaseRemeasurements	0	usd
CY2022Q1	pcor	Noncash Net Change Due To Operating Lease Remeasurements NoncashNetChangeDueToOperatingLeaseRemeasurements	-1676000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-indent:24.48pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:12pt;text-indent:24.48pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management periodically evaluates its estimates and assumptions for continued reasonableness, primarily with respect to revenue recognition, the period of benefit of contract cost assets, the fair value of assets acquired and liabilities assumed in a business combination, stock-based compensation expense, including the fair value of the Company’s common stock prior to the effective date of the Company’s initial public offering (“IPO”), the recoverability of goodwill and long-lived assets, useful lives of long-lived assets, capitalization of software development costs, income taxes, including related reserves and allowances, and self-insurance reserve estimates. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. Management bases its estimates on historical experience and on various other assumptions that management believes to be reasonable. Actual results could differ from the Company's estimates.</span></div>
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2023Q1	us-gaap	Receivables From Customers ReceivablesFromCustomers	17000000	usd
CY2022Q4	us-gaap	Receivables From Customers ReceivablesFromCustomers	13600000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	3400000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2100000	usd
CY2023Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	2100000	usd
CY2022Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	1900000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:6pt;text-indent:24.48pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk</span></div><div style="margin-bottom:12pt;text-indent:24.48pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash, cash equivalents, and marketable securities balances with major financial institutions that typically exceed federally insured limits. Following the closure of Silicon Valley Bank in March 2023, the Company’s checking, saving, and investment accounts were subsequently assumed by First Citizens Bank & Trust Company (“First Citizens Bank”). As of March 31, 2023, less than 1% of the Company's total cash, cash equivalents, and marketable securities balances were held in deposit accounts at First Citizens Bank, and all other amounts with First Citizens Bank were held in money market funds. The vast majority of the Company's cash and cash equivalents balances were held in the form of money market funds at other large, global financial institutions.</span></div>
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	171500000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	128200000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	805500000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.73
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	274029000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	124000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	308000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	273845000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	286001000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	14000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	522000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	285493000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	103900000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022Q4	us-gaap	Investments Investments	11043000	usd
CY2023Q1	pcor	Interest Accrued On Available For Sale Debt Securities InterestAccruedOnAvailableForSaleDebtSecurities	2000	usd
CY2023Q1	pcor	Payments To Acquire Strategic Investments PaymentsToAcquireStrategicInvestments	149000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	36000	usd
CY2023Q1	us-gaap	Investments Investments	11230000	usd
CY2021Q4	us-gaap	Investments Investments	7332000	usd
CY2022Q1	pcor	Interest Accrued On Available For Sale Debt Securities InterestAccruedOnAvailableForSaleDebtSecurities	101000	usd
CY2022Q1	pcor	Payments To Acquire Strategic Investments PaymentsToAcquireStrategicInvestments	2329000	usd
CY2022Q1	pcor	Conversion Of Securities ConversionOfSecurities	0	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	42000	usd
CY2022Q1	us-gaap	Investments Investments	9804000	usd
CY2023Q1	pcor	Impairment Losses On Strategic Investments ImpairmentLossesOnStrategicInvestments	0	usd
CY2022Q1	pcor	Impairment Losses On Strategic Investments ImpairmentLossesOnStrategicInvestments	0	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	582824000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	316048000	usd
CY2023Q1	pcor	Operating Lease Right Of Use Assets Operating Lease Liabilities OperatingLeaseRightOfUseAssetsOperatingLeaseLiabilities	2600000	usd
CY2022Q1	pcor	Operating Lease Right Of Use Assets Operating Lease Liabilities OperatingLeaseRightOfUseAssetsOperatingLeaseLiabilities	7000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	223483000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	69861000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	153622000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P4Y9M18D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	223480000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	60527000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	162953000	usd
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y1M6D
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9334000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9662000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	539100000	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	pcor	Accrued Commissions And Bonuses Current AccruedCommissionsAndBonusesCurrent	8350000	usd
CY2022Q4	pcor	Accrued Commissions And Bonuses Current AccruedCommissionsAndBonusesCurrent	28357000	usd
CY2023Q1	pcor	Accrued Commissions AccruedCommissions	9523000	usd
CY2022Q4	pcor	Accrued Commissions AccruedCommissions	20389000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	37770000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	34113000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13982000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16323000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	69625000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	99182000	usd
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	45000000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5723772	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.65
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	272032	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	13.42
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3897	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	22.58
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5447843	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.61
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5362988	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.41
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	600000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y3M18D
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44938000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37209000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2122000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2166000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	47060000	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	39375000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14191239	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14402567	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	213526000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	159516000	usd

Files In Submission

Name	View Source	Status
0001628280-23-016126-index-headers.html	Edgar Link	pending
0001628280-23-016126-index.html	Edgar Link	pending
0001628280-23-016126.txt	Edgar Link	pending
0001628280-23-016126-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcor-20230331.htm	Edgar Link	pending
pcor-20230331.xsd	Edgar Link	pending
pcor-2023q1xexx311.htm	Edgar Link	pending
pcor-2023q1xexx312.htm	Edgar Link	pending
pcor-2023q1xexx321.htm	Edgar Link	pending
pcor-2023q1xexx322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pcor-20230331_cal.xml	Edgar Link	unprocessable
pcor-20230331_def.xml	Edgar Link	unprocessable
pcor-20230331_lab.xml	Edgar Link	unprocessable
pcor-20230331_pre.xml	Edgar Link	unprocessable
pcor-20230331_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCOR
PROCORE TECHNOLOGIES, INC. Stock $pcor

2023 Q2 Form 10-Q Financial Statement

#000162828023016126 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCOR PROCORE TECHNOLOGIES, INC. Stock $pcor

2023 Q2 Form 10-Q Financial Statement

#000162828023016126 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCOR
PROCORE TECHNOLOGIES, INC. Stock $pcor